ResMed (RMD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.98 +0.61%
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
